Stefano Di Biase
About Stefano Di Biase
Stefano Di Biase is a Senior Scientist at Kite Pharma, where he has worked since 2022. He holds a PhD in Aging Related Diseases/Cancer Immunology from the University of Southern California and has extensive experience in biochemistry and biotechnologies.
Work at Kite Pharma
Stefano Di Biase has been employed at Kite Pharma as a Senior Scientist since 2022. His role at Kite Pharma focuses on advancing research in the field of cancer immunology. Prior to his current position, he worked as a Scientist at Kite Pharma for four years, starting in 2018. His contributions to the organization are centered around innovative approaches to cancer treatment, leveraging his extensive background in biochemistry and immunology.
Education and Expertise
Stefano Di Biase earned a Doctor of Philosophy (PhD) in Aging Related Diseases and Cancer Immunology from the University of Southern California, where he studied from 2011 to 2016. He also holds a Bachelor of Science (BSc) in Biochemistry and a Master of Science (MS) in Biotechnologies from Sapienza Università di Roma, completing his studies there from 2003 to 2010. His educational background provides a strong foundation for his research in the biomedical field.
Background
Before joining Kite Pharma, Stefano Di Biase worked as a Postdoctoral Researcher at UCLA from 2016 to 2018. He also served as a PhD student at the University of Southern California from 2011 to 2016. Additionally, he gained experience as a Research Assistant at the USC Davis School of Gerontology from 2010 to 2016. His diverse research experiences have contributed to his expertise in cancer immunology and aging-related diseases.
Achievements
Stefano Di Biase's academic and professional journey includes significant contributions to research in aging-related diseases and cancer immunology. His work during his PhD and postdoctoral studies has laid the groundwork for his current role at Kite Pharma, where he continues to engage in impactful research. His educational qualifications and research experiences reflect a commitment to advancing knowledge in the biomedical sciences.